Jiangning Liu Selected Research

Jiangning Liu Research Topics

Disease

21	Infections 05/2024 - 03/2012
20	COVID-19 04/2024 - 01/2020
6	Inflammation (Inflammations) 04/2024 - 01/2020
5	Rhabdomyosarcoma 05/2013 - 10/2011
3	Communicable Diseases (Infectious Diseases) 05/2024 - 03/2012
3	Virus Diseases (Viral Diseases) 05/2024 - 01/2016
3	Pneumonia (Pneumonitis) 11/2021 - 01/2021
2	Foot and Mouth Disease Hand (Hand, Foot, Mouth Disease) 05/2024 - 01/2020
2	Fibrosis (Cirrhosis) 04/2024 - 11/2022
2	Cytokine Release Syndrome 12/2023 - 01/2021
1	Neoplasms (Cancer) 05/2024
1	Amyloidosis 04/2024
1	Insulin Resistance 04/2024
1	Necrosis 04/2024
1	Critical Illness (Critically Ill) 01/2024
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2024
1	Emerging Communicable Diseases (Emerging Infectious Diseases) 12/2023
1	Shock 12/2023
1	Viral Encephalitis 12/2022
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 11/2022
1	Weight Gain 11/2022
1	Coronavirus Infections 10/2021
1	Convalescence 01/2020
1	Tuberculosis (Tuberculoses) 03/2012
1	Paralysis (Palsy) 10/2011
1	Pulmonary Embolism 07/2011
1	Confusion (Bewilderment) 07/2011
1	Thrombosis (Thrombus) 07/2011

Drug/Important Bio-Agent (IBA)

18	VaccinesIBA 04/2024 - 03/2012
6	Proteins (Proteins, Gene)FDA Link 01/2023 - 07/2011
4	Antiviral Agents (Antivirals)IBA 01/2023 - 09/2015
3	RNA (Ribonucleic Acid)IBA 05/2024 - 11/2022
3	CytokinesIBA 12/2023 - 01/2018
3	EpitopesIBA 11/2020 - 01/2016
3	AntibodiesIBA 01/2020 - 01/2016
3	AntigensIBA 01/2020 - 01/2020
2	antineoplaston A10 (A 10)IBA 05/2024 - 02/2024
2	Blood Glucose (Blood Sugar)IBA 04/2024 - 01/2021
2	Insulin (Novolin)FDA Link 04/2024 - 01/2021
2	reluscovtogene ralaplasmidIBA 12/2022 - 01/2020
2	DNA VaccinesIBA 12/2022 - 03/2012
2	meplazumabIBA 11/2022 - 01/2021
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2022
2	ChemokinesIBA 01/2021 - 01/2018
2	Neutralizing AntibodiesIBA 01/2020 - 01/2020
2	Peptides (Polypeptides)IBA 01/2020 - 01/2016
2	Viral RNAIBA 01/2020 - 08/2012
1	N-(2-cyanoethylene)urea (BA 1)IBA 05/2024
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 04/2024
1	C-PeptideIBA 04/2024
1	CollagenIBA 04/2024
1	Glucose (Dextrose)FDA LinkGeneric 04/2024
1	Toll-Like Receptors (Toll-Like Receptor)IBA 12/2023
1	SARS-CoV-2 spike proteinIBA 12/2022
1	Neuropilin-1IBA 12/2022
1	Bleomycin (Blenoxane)FDA LinkGeneric 11/2022
1	COVID-19 VaccinesIBA 01/2022
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022
1	LipidsIBA 01/2022
1	Antihypertensive Agents (Antihypertensives)IBA 01/2022
1	Biocompatible Materials (Biomaterials)IBA 01/2022
1	paquinimodIBA 10/2021
1	AlarminsIBA 10/2021
1	Interleukin-17 (Interleukin 17)IBA 01/2021
1	Cyclophilin AIBA 01/2021
1	MucinsIBA 12/2020
1	InterferonsIBA 12/2020
1	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 12/2020
1	Pudilan xiaoyanIBA 01/2020
1	BIBP COVID-19 vaccineIBA 01/2020
1	A-Form DNA (A-DNA)IBA 01/2020
1	vesatolimodIBA 01/2018
1	Glycoproteins (Glycoprotein)IBA 01/2016
1	Deferoxamine (Desferal)FDA LinkGeneric 07/2014
1	chebulagic acidIBA 05/2013
1	punicalaginIBA 12/2012
1	MatrinesIBA 08/2012
1	pAEH vaccineIBA 03/2012
1	Therapeutic UsesIBA 03/2012
1	GeraniinIBA 03/2012
1	P-selectin ligand proteinIBA 03/2012
1	lycorineIBA 10/2011

Therapy/Procedure

3	Therapeutics 01/2023 - 09/2015
1	Intraperitoneal Injections 05/2024
1	Immunotherapy 01/2024